Physician profile
Vincent Siebert
NPI 1477089514
$4,237.85
in general payments reported to CMS, 2019-2025
17 companies · $753 in 2025
The $753 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $441 · 2023: $1,353 · 2024: $1,555 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,367 · Grant: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,366.90 |
| Grant | $294.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,111.56 | 2023-2025 | Rotapro, Avvigo Guidance System, Watchman Access System |
| Abbott Laboratories | $1,002.34 | 2021-2025 | Mitraclip, Amplatzer Amulet, Perclose Prostyle |
| Abiomed | $368.26 | 2024-2025 | Impella |
| Shockwave Medical, INC | $298.89 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Teleflex LLC | $286.76 | 2023-2024 | Guideliner |
| Medtronic, INC. | $265.94 | 2023-2024 | Onyx Frontier |
| Philips North America LLC | $143.36 | 2025 | Coronary Undivided |
| Penumbra, INC. | $141.25 | 2024 | Indigo System |
| Biotronik INC. | $139.33 | 2023-2024 | Orsiro Mission |
| Janssen Pharmaceuticals, INC | $138.86 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $124.45 | 2022 | |
| Heartflow, INC. | $112.68 | 2023-2025 | Ffrct |
| Cleerly, INC. | $34.24 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Esperion Therapeutics, INC. | $20.34 | 2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.79 | 2023 | Lifevest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.31 | 2023 | Wainua |
| Pfizer INC. | $15.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Siebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.